India, Nov. 9 -- Healthcare stocks moved higher following clinical and corporate updates. Edesa Biotech signed an exclusive licensing agreement with Japan's KYORIN Pharmaceutical for its ARDS candidate, Delcath Systems reported strong third-quarter results and raised its full-year outlook, Immunovant reported positive Phase 2 rheumatoid arthritis data, and Vir Biotechnology announced encouraging long-term hepatitis delta virus findings.
Read on.....
Edesa Biotech, Inc.(EDSA)
Shares surged 30% after Edesa Biotech signed an exclusive licensing agreement with Japan's KYORIN Pharmaceutical for paridiprubart in acute respiratory distress syndrome (ARDS). Edesa will receive $12 million upfront, up to approximately $134 million in milestone pay...